| Product Name | Enhanced Green Fluorescent Protein, EGFP (200-208) |
| Purity | HPLC>95% |
| Description | This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer. |
| Storage | -20°C |
| References | Wysocki, P. et al. Clin Cancer Res 12, 4095 (2006); Sharma, S. et al. J Immunol 177, 8348 (2006); Wingender, G. et al. Eur J Immunol 36, 12 (2006); Gambotto, A. et al. Gene Ther 7, 2036 (2000). |
| Molecular Weight | 1019.1 |
| Sequence (One-Letter Code) | HYLSTQSAL |
| Sequence (Three-Letter Code) | H - His - Tyr - Leu - Ser - Thr - Gln - Ser - Ala - Leu - OH |
Enhanced Green Fluorescent Protein, EGFP (200-208)Admin2021-01-06T05:51:58+00:00
